Canbex Therapeutics' Grant

Canbex Therapeutics raised a round of funding on September 01, 2013. Investors include Innovate UK.

Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and potentially other disorders. Spasticity is a debilitating and painful symptom of MS that consists of involuntary …

Articles about Canbex Therapeutics' Grant: